A Food and Drug Administration advisory committee voted that the benefits of a seasonal flu vaccine from Moderna outweigh its risks, part of the agency’s review of a potential new treatment

13 hours ago 2

1. Homepage
2. Health
3. A Food and Drug Administration advisory committee voted that the benefits of a seasonal flu vaccine from Moderna outweigh its risks, part of the agency’s review of a potential new treatment